Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)
Egypt · Delayed Price · Currency is EGP 3.090
-0.080 (-2.52%)
At close: Dec 4, 2025
EGX:RMDA Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 421.13 | 387.37 | 244.86 | 245.68 | 181.09 | 112.18 | Upgrade |
Depreciation & Amortization | 109.36 | 83.43 | 72.88 | 65.48 | 46.18 | 56.2 | Upgrade |
Loss (Gain) From Sale of Assets | -0.13 | -0.01 | -0.14 | 0.13 | 0.72 | 0.14 | Upgrade |
Asset Writedown & Restructuring Costs | 2.51 | 2.51 | - | - | - | - | Upgrade |
Stock-Based Compensation | 5.82 | 16.29 | 17.77 | 17.85 | - | - | Upgrade |
Provision & Write-off of Bad Debts | 9.71 | 11.44 | 3.81 | 3.64 | 0.11 | 1.8 | Upgrade |
Other Operating Activities | 102.3 | 9.24 | 2.42 | -8.44 | -10.39 | -34.27 | Upgrade |
Change in Accounts Receivable | -677.02 | -218.62 | -374.86 | -243.64 | -29.45 | -135.89 | Upgrade |
Change in Inventory | -702.88 | -439.51 | 30.97 | -88.59 | 47.58 | -100.76 | Upgrade |
Change in Accounts Payable | 231.63 | 276.38 | 16.97 | 68.59 | 31.51 | -36.53 | Upgrade |
Change in Other Net Operating Assets | 95.76 | -435.45 | -59.17 | -31.35 | -25.99 | -27.2 | Upgrade |
Operating Cash Flow | -401.8 | -306.92 | -44.5 | 29.35 | 241.35 | -164.32 | Upgrade |
Operating Cash Flow Growth | - | - | - | -87.84% | - | - | Upgrade |
Capital Expenditures | -111.31 | -64.93 | -91.05 | -34.38 | -52.67 | -84.99 | Upgrade |
Sale of Property, Plant & Equipment | 1.84 | 1.72 | 0.18 | 0.02 | 0.02 | 0.07 | Upgrade |
Sale (Purchase) of Intangibles | -585.45 | -1.71 | -162.44 | -93.9 | -185.53 | -116.14 | Upgrade |
Investment in Securities | 290.7 | 120.66 | 194.68 | 167.47 | 68.06 | 48.81 | Upgrade |
Other Investing Activities | -93.84 | -93.84 | - | - | - | - | Upgrade |
Investing Cash Flow | -404.23 | -38.09 | -58.63 | 39.22 | -170.11 | -152.24 | Upgrade |
Short-Term Debt Issued | - | 1,998 | 1,421 | 1,205 | 1,172 | 1,047 | Upgrade |
Total Debt Issued | 3,175 | 1,998 | 1,421 | 1,205 | 1,172 | 1,047 | Upgrade |
Short-Term Debt Repaid | - | -1,551 | -1,265 | -1,121 | -1,156 | -728.92 | Upgrade |
Long-Term Debt Repaid | - | -6.34 | -5.74 | -27.14 | -71.19 | -41.76 | Upgrade |
Total Debt Repaid | -2,146 | -1,558 | -1,271 | -1,149 | -1,228 | -770.68 | Upgrade |
Net Debt Issued (Repaid) | 1,029 | 440.9 | 149.72 | 56.96 | -55.09 | 276.46 | Upgrade |
Issuance of Common Stock | 1.88 | 3.23 | 2.11 | - | - | - | Upgrade |
Repurchase of Common Stock | - | - | - | -65.93 | - | - | Upgrade |
Common Dividends Paid | -178.91 | -121.28 | -16.76 | -24.31 | -14.7 | - | Upgrade |
Financing Cash Flow | 851.92 | 322.86 | 135.07 | -33.28 | -69.79 | 276.46 | Upgrade |
Foreign Exchange Rate Adjustments | -54.07 | 34.48 | 0.42 | 17.22 | -0.19 | -0.73 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | 0 | - | - | - | - | Upgrade |
Net Cash Flow | -8.17 | 12.32 | 32.37 | 52.51 | 1.26 | -40.84 | Upgrade |
Free Cash Flow | -513.12 | -371.85 | -135.54 | -5.03 | 188.68 | -249.31 | Upgrade |
Free Cash Flow Margin | -13.00% | -13.43% | -7.05% | -0.34% | 15.14% | -25.96% | Upgrade |
Free Cash Flow Per Share | -0.26 | -0.19 | -0.07 | -0.00 | 0.09 | -0.12 | Upgrade |
Cash Interest Paid | 496.53 | 294.66 | 186.52 | 84.82 | 89.41 | 94.95 | Upgrade |
Cash Income Tax Paid | 104.95 | 67.07 | 60.69 | 44.29 | 28.91 | 29.97 | Upgrade |
Levered Free Cash Flow | -1,198 | -554.12 | -381.77 | -108.98 | -7.86 | -378.52 | Upgrade |
Unlevered Free Cash Flow | -882.02 | -362.11 | -262.27 | -53.32 | 49.03 | -318.11 | Upgrade |
Change in Working Capital | -1,053 | -817.2 | -386.09 | -295 | 23.64 | -300.37 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.